Sutro Biopharma (STRO) has provided an announcement.
Sutro Biopharma, Inc. has appointed Sukhi Jagpal as a Class III director and member of the Audit Committee, with his directorship beginning on August 8, 2024, and committee membership starting on August 15, 2024. As part of his compensation, Jagpal will receive prorated annual retainers and stock options vesting over three years and until the 2025 annual meeting, respectively, provided he continues his service with the company. This appointment involves no familial ties or material interests in company transactions that would necessitate disclosure.
Learn more about STRO stock on TipRanks’ Stock Analysis page.
